Year: 2021

Data from the MONALEESA Phase III program provide further evidence of the unique profile of Kisqali, the CDK4/6 inhibitor with the longest reported median overall survival (OS) in HR+/HER2- metastatic breast cancer (over 5 years) and proven OS benefit across patient subgroups1-5Kisqali pooled data at the San Antonio Breast Cancer Symposium confirms OS benefit across most common genomic intrinsic subtypes of HR+/HER2- metastatic breast cancer, including the aggressive, ET-resistant HER2-enriched subtype6     Data supports rationale for HARMONIA, the first prospective, head-to-head Phase III trial seeking to identify the best therapeutic option between Kisqali and Ibrance®* for patients with the HER2-enriched subtypeKisqali remains the only CDK4/6i with consistent OS benefit across the entire MONALEESA program, regardless of site...

Quincy, Mass, Dec. 08, 2021 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: STRN) (NASDAQ: STRNW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that it entered into a securities purchase agreement with certain institutional investors to purchase approximately $21.7 million worth of its common stock and warrants in a private placement. Under the terms of the securities purchase agreement, Stran has agreed to sell 4,371,926 shares of its common stock and warrants to purchase 5,464,907 shares of common stock. The warrants will be exercisable immediately upon the date of issuance and have an exercise price of $4.97 per share. The warrants will expire five years from the date of issuance....

CHARLOTTESVILLE, Va., Dec. 08, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Cary J. Claiborne as Chief Operating Officer. Mr. Claiborne will continue to serve on the Board of Directors. In his new role, Mr. Claiborne will be responsible for overseeing the Company’s strategic growth initiatives, including commercial preparations for AD04, advancement of the clinical pipeline, as well as identifying potential strategic/partnering opportunities related to addiction and the Company’s adenosine platform through its wholly-owned subsidiary, Purnovate, Inc. Joseph Truluck who previously served as Chief Operating Officer and Chief...

ATHENS, Greece, Dec. 08, 2021 (GLOBE NEWSWIRE) — STEALTHGAS INC. (NASDAQ: GASS), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today its unaudited financial and operating results for the third quarter and nine months ended September 30, 2021. STRATEGIC, OPERATIONAL AND FINANCIAL HIGHLIGHTS1Successful spin-off of our four tankers concluded on December 3, 2021 to a new listed entity called Imperial Petroleum Inc. This spin-off allows the creation of two businesses in distinct sectors of the shipping industry, LPG carriers and tankers. Fleet utilization of 97.4% – with 101 days of technical off hire mainly as a result of the completion of two drydockings with two ballast water system installations and the partial completion of another two drydockings...

Patient Monitors IntelliVue MX750 and IntelliVue 850 are Philips most advanced patient monitors yetPatient Monitors IntelliVue MX750 and IntelliVue 850December 08, 2021 Philips Patient Monitors IntelliVue MX750 and IntelliVue MX850 pair with advanced software and services to offer clinical decision support, continuous, scalable patient management and enhanced infection control Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its Philips Patient Monitors MX750 and MX850 have received 510(k) clearance from the U.S. Food and Drug Administration. Initially cleared for Emergency Use Authorization in 2020, the MX750 and MX850 are Philips’ most advanced patient monitors uniquely designed to support scalability, alarm management, cybersecurity...

ENGLEWOOD, Colo., Dec. 08, 2021 (GLOBE NEWSWIRE) —  Evolving Systems, Inc. (NASDAQ: EVOL), a leader in real-time digital engagement, has announced a collaboration with Amdocs to deliver optional capabilities for the new Amdocs Digital Brands Suite-as-a-Service offering, which enables CSPs to create game-changing digital experiences for their digital brand customers. Evolving Systems is one of several suite partners and the company will deliver loyalty and campaigns capabilities for the suite customers. The cloud-based software-as-a-service business suite enables digital brands to introduce experiences that are simple and faster than ever before, with a ‘pay-as-you-grow’ business model allowing for flexible growth without large commitments. It supports a market in which digital communications brands must deliver unique and dynamic...

VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”), a global leader in vacuum-microwave dehydration technology, announced today it will report its financial results for the fourth quarter and for the fiscal year 2021 ended September 30, 2021 on Wednesday, December 15, 2021 after market close. The financial statements and MD&A will be available on SEDAR at www.sedar.com and on the Company’s website in the late evening Vancouver time. The Company has scheduled a conference call to discuss the results for Q4 2021 and business outlook on Thursday, December 16, 2021 at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). Brent Charleton, Chief Executive Officer and Dan Henriques, Chief Financial Officer will present EnWave’s results and host...

SUNNYVALE, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) — NextNav (Nasdaq: NN), a leader in next generation GPS, today announced a partnership with Bosch Sensortec, the leading provider in sensing solutions for consumer electronics, to enable more precise vertical location in barometric pressure sensors. Bosch Sensortec’s barometric pressure sensors will undergo rigorous testing through the NextNav Certified program to certify their accuracy and performance meet stringent standards across a variety of use cases. Through the partnership, Bosch Sensortec will validate the accuracy of measurements and provide robust performance assurance for Original Equipment Manufacturers (OEMs) utilizing its sensors in mass-market products including mobile phones, tablets, and wearables. “Our barometric pressure sensors produce highly accurate altitude...